John Kelly
Analyst · Truist. Your question please
Thank you, Jim, and good afternoon, everyone. Before I begin, please note that I will be discussing non-GAAP financial measures such as EBITDA, adjusted EBITDA, adjusted net income, adjusted EPS and free cash flow. Our press release, 10-Q and Investor Relations page on the Huron website have reconciliations of these non-GAAP measures to the most comparable GAAP measures, along with the discussion of why management uses these non-GAAP measures and why management believes they provide useful information to investors regarding our financial condition and operating results. Now let me walk you through some of the key financial results for the quarter. Revenues for the third quarter of 2022 were $285.4 million, up 27.4% from $224 million in the same quarter of 2021. The increase in revenues in the quarter was nearly entirely organic and driven by growth across all 3 operating segments, particularly our Education and Healthcare segments and was reflected on the strong demand for our digital offerings across all industries. Revenue within our digital capability increased 45% in the third quarter of 2022 over the same period in 2021. In addition, revenues reflect continued strong demand for our Consulting and Managed Service offerings within the Education and Healthcare segments, which grew 46% and 17%, respectively, in the third quarter of 2022 over the same period in 2021. Net income was $17.7 million or $0.86 per diluted share in the third quarter of 2022, compared to $13.7 million or $0.64 per diluted share in the same quarter in the prior year. Our effective income tax rate in the third quarter of 2022 was 30.2% compared to 12.5% 1 year ago. Our effective tax for Q3 of 2022 was less favorable than the statutory rate, inclusive of state income taxes, primarily due to tax expense related to nondeductible losses and the investments used to fund our deferred compensation liability and certain nondeductible expense items. Adjusted EBITDA was $36.5 million in Q3 2022 or 12.8% of revenues compared to $26.4 million in Q3 of 2021 or 11.8% of revenues. Adjusted non-GAAP net income was $20.7 million or $1.01 per diluted share in the third quarter of 2022 compared to $16.8 million or $0.78 per diluted share in the same period of 2021. Now I’ll make a few comments about the performance of each of our operating segments. The Healthcare segment generated 46% of total company revenues during the third quarter of 2022. This segment posted revenues of $131.3 million during the quarter, up $26.7 million or 25.5% from the third quarter of 2021. Revenues for the third quarter of 2022 included $1.2 million from our acquisition of Perception Health, which was completed in December of 2021. The increase in revenue in the quarter reflects strong demand for our digital offerings as well as our financial advisory revenue cycle managed services and performance improvement offerings. The digital capability in Healthcare grew by 49%, reflecting increased demand for our ERP and electronic health record offerings. Operating income margin for Healthcare was 25.2% for Q3 of 2022 compared to 30.7% for the same quarter in 2021. The quarter-over-quarter decrease in margin percentage is primarily attributable to the mix of the strength of our digital offerings during the quarter in our investments and head count growth that we believe will drive continued growth for this industry into 2023. The Education segment generated 33% of total company revenues during the third quarter of 2022. The segment posted record revenues of $94.3 million in Q3 2022, up $31.1 million or 49.2% from the third quarter of 2021. Revenues in the third quarter of 2022 included $2.2 million from our acquisition of Whiteboard, which was completed in December of 2021. The increase in revenue reflects the continued strong demand for all of our offerings across the segment, including digital capability growth in the Education segment of 53%. The third quarter of 2022 represented the seventh consecutive quarter of sequential growth for the Education segment. The operating income margin for Education was 24.2% for Q3 2022 compared to 23% for the same quarter in 2021. The quarter-over-quarter increase in margin was primarily due to revenue growth that outpaced our corresponding cost to deliver during the quarter, partially offset by investments in headcount growth, technology expenses, in cloud-based training – cloud-based technology training that we expect will drive continued strong growth for this industry into 2023. The Commercial segment generated 21% of total company revenues during the third quarter of 2022. Segment posted revenues of $59.7 million in Q3 2022, up $3.6 million or 6.3% from the third quarter of 2021. Revenues for the third quarter of 2022 included $400,000 of inorganic contributions from our acquisition of AIMDATA which was completed in January of 2022. The increase in revenues reflect continued strong demand for our digital offerings, partially offset by a decline in revenues due to the divestiture of our Life Sciences business in the fourth quarter of 2021 as well as a decrease in demand for our financial advisory and strategy and innovation offerings. In the third quarter of 2021, the Life Sciences business generated revenues of $5.1 million. Our digital offerings in the commercial markets grew 35% in the third quarter of 2022 as compared to the same period a year ago. The operating income margin for the Commercial segment was 23.7% for Q3 2022, compared to 14.7% for the same quarter in 2021. The increase in operating income margin for this segment was primarily due to the revenue growth in this segment, coupled with a decrease in direct costs during the quarter, which was primarily due to the Life Sciences divestiture in the fourth quarter of 2021. Corporate expenses not allocated to the segment level were $35.7 million or 12.5% of revenues in Q3 2022 compared with $31.4 million or 14% of revenues in Q3 2021. Unallocated corporate expenses in the third quarter of 2022 included a $1.3 million reduction of expense related to the decrease in liability to participants in our deferred compensation plan, which is fully offset by the corresponding loss and other income related to the decrease in fair value of the assets used to fund that plan. Unallocated corporate expenses in the third quarter of 2021 reflected a similar reduction of expense of $200,000 related to the deferred compensation plan. Absent the impact of our deferred compensation plan in both periods, unallocated corporate expenses increased $5.4 million, which is primarily due to increases in salaries, bonus and related expenses for our support personnel. Now turning to the balance sheet and cash flows. We finished the quarter with borrowings on our revolving credit facility of $341 million with cash of $9 million for net debt of $332 million. Third quarter included $45.6 million of share repurchases or approximately 686,000 shares. On a year-to-date basis, we repurchased 1.7 million shares, representing 7.8% for our outstanding shares as of the beginning of the year. Our leverage ratio is defined in our senior bank agreement, was approximately 2.1x adjusted EBITDA as of September 30, 2022, compared to 2.7x adjusted EBITDA at the end of the third quarter of 2021. As of September 30, 2022, $32.3 million remained available for share repurchases under our current authorization. In October of 2022, our Board of Directors increased our authorization for share repurchases by another $100 million. Cash flow generated from operations in the third quarter of 2022 was $44.4 million and we used $5.8 million of our cash to invest in capital expenditures, inclusive of internally developed software costs, resulting in free cash flow of $38.6 million. DSO came in at 85 days for the third quarter of 2022, compared to 81 days for the second quarter of 2022 and 76 days for the third quarter of 2021. The increase in DSO was reflective of the pace of revenue growth during the year and certain larger healthcare and education industry projects with extended billing and payment terms, which are normal and our mix of business intend to ebb and flow over time. Finally, let me turn to our expectations and guidance for 2022. As Jim noted, we are raising and narrowing our full year 2022 revenue guidance to be in a range of $1.09 billion to $1.11 billion. The increase in our revenue guidance primarily reflects strong momentum across our business and the significant growth opportunities in each of our core industries. In addition, we continue to expect our full year adjusted EBITDA to be in a range of 11.5% to 12% of revenues, and we are narrowing our full year adjusted non-GAAP diluted earnings per share guidance to be in a range of $3.25 to $3.35. The midpoint of our adjusted EPS range is consistent with our expectations as of our second quarter call, now reflecting increased adjusted EBITDA expectations and a reduced diluted share count, offset by increased interest and income tax expense related primarily to increased interest rates and the tax impact of the decline in value of the assets used to fund our nonqualified deferred compensation plan. Finally, we expect our full year effective tax rate to be in a range of 30% to 32% and we continue to expect full year free cash flow in a range of $70 million to $90 million. Thanks, everyone. Before we open the call for questions, I’d like to turn the call back over to Jim for some additional remarks.